Italian Pilot Study of Cardiogenic Shock Treatment
Part of Heart & circulation clinical trials.
This study tracks how well people with cardiogenic shock (a life-threatening drop in blood flow after a heart attack or heart failure worsening) do when treated with modern support devices and medicines.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 75 years old.
- You must have cardiogenic shock (very low blood pressure needing medications or a device) caused by a heart attack or worsening heart failure.
- You cannot have had a cardiac arrest with no heartbeat for more than 10 minutes or prolonged CPR.
- You cannot have a condition that makes it unsafe to use a heart support device.
- Your shock must not be from another cause (like infection or bleeding).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing different approaches (medications and mechanical support) to help people with acute heart failure and cardiogenic shock (a sudden drop in the heart's pumping ability). It looks at how well these treatments work in a network of hospitals to improve outcomes.
This study looks at how people with cardiogenic shock (or very low blood pressure from heart causes) do after treatment in a specialized cardiovascular ICU. It also examines whether care by heart critical-care specialists affects outcomes.
This study looks at how well a temporary heart pump helps people who have had a heart attack complicated by cardiogenic shock. The pump supports the heart while doctors restore blood flow, which may improve recovery.
This trial tests if unloading the heart during ECMO support helps patients recover better from cardiogenic shock. It compares different ways to reduce the heart's workload.
This study looks at whether a person’s genetic information (genomics) can help predict outcomes in cardiogenic shock. You may be asked to give consent and provide information during a serious heart-related emergency, usually soon after symptoms start.
This study collects information from people with cardiogenic shock (a condition where the heart cannot pump enough blood for the body) to improve future care. You will not receive any new treatment, but your participation helps doctors understand and manage this condition better.
Hear when a new Cardiogenic Shock trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.